P/B
8,6
Heron Therapeutics
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
$59.5M
Market Cap • 9/30/2026
1983
(43 years)
Founded
1987
(39 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,4
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0
EPS
—
Market Cap
Market Cap
59,5M
EV
166,3M
EV/Revenue
1,1
EV/EBITDA
-19
EV/EBIT
-15,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-31,1%
Total Yield
-31,1%
Payout
0%
Retained Earnings
-2B
Profitability
Gross Margin
70,1%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
8,1%
Capex/Revenue
0,3%
Capex/D&A
24,8%
Capex/OCF
-4,6%
SBC/OCF
—
% PPE
6,9%
% Goodwill
0%
ROE
334,6%
ROIC
—
Growth
CAGR Revenue 5Y
12,7%
CAGR Op. Income 5Y
-45,8%
CAGR Net Income 5Y
-32%
CAGR EPS 5Y
-40,4%
CAGR OCF 5Y
-43,4%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
2,5
Quick Ratio
1,4
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!